Citation Impact
Citing Papers
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
2008 StandoutScience
Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia.
1989
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
Human conditions of insulin-like growth factor-I (IGF-I) deficiency
2012
Apoptosis in neurodegenerative disorders
2000
Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
1992
Immunopathogenesis of inflammatory myopathies
1995
The Membrane Attack Complex of Complement at the Endplate in Myasthenia Gravisa
1987
Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease
1988
Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
1992 StandoutNobel
Long-term observational study of sporadic inclusion body myositis
2011
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Paraproteinemic Neuropathies
2001
The metabolic syndrome
2010 Standout
Mutation of the Prion Protein in Libyan Jews with Creutzfeldt–Jakob Disease
1991 StandoutNobel
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
2006
Guillain-Barré syndrome
2016 Standout
From charcot to lou gehrig: deciphering selective motor neuron death in als
2001
The free-energy principle: a unified brain theory?
2010 Standout
Mitochondrial formation of reactive oxygen species
2003 Standout
Transcriptional profile of primary astrocytes expressing ALS‐linked mutant SOD1
2008
Amyotrophic lateral sclerosis
2011 Standout
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
2004
The Relationship of Complement-Mediated Microvasculopathy to the Histologic Features and Clinical Duration of Disease in Dermatomyositis
1991
Cell Death
2004 Standout
The management of motor neurone disease
2003
The participation of coenzyme Q in free radical production and antioxidation
1990
Myasthenia Gravis
1994 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches
2002
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
1992 Standout
Protein aggregation and neurodegenerative disease
2004 Standout
The metabolic syndrome
2005 Standout
Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients
1991
Oxidative capacity correlates with muscle mutation load in mitochondrial myopathy
2003
Effects of oral supplementation of coenzyme Q10 on 31P-NMR detected skeletal muscle energy metabolism in middle-aged post-polio subjects and normal volunteers
1997
Cerebral Sinovenous Thrombosis in Children
2001 Standout
Diagnostic investigation and multidisciplinary management in motor neuron disease
2005
Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders
2000
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
1998 Standout
The induction of pain: an integrative review
1999
Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories
2004
Experimental conduction block induced by serum from a patient with anti‐GM1 antibodies
1992
A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies
1990 StandoutNature
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
1988
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters
2005
Novel drug development for amyotrophic lateral sclerosis
2000
Polymyositis and dermatomyositis
2003 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
1994 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Nociceptors: the sensors of the pain pathway
2010 StandoutNobel
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Microvascular changes in early and advanced dermatomyositis: A quantitative study
1990
Neurotrophic factors and neuro-muscular disease: II. GDNF, other neurotrophic factors, and future directions
1999
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection
2004
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Distribution of capillaries in normal and diseased human skeletal muscle
1986
Amyotrophic lateral sclerosis
2000
Clinical Trials in Motor Neuron Diseases
1999
Epidemiology of inclusion body myositis in the Netherlands: A nationwide study
2000
Inflammatory Muscle Diseases
2015 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
1998 Standout
ALSUntangled Update 1: Investigating a bug (Lyme Disease) and a drug (Iplex) on behalf of people with ALS
2009
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
2002 Standout
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
L-glutamate decarboxylase and Choline acetyltransferase activity in the substantia nigra and the striatum after surgical interruption of the strio-nigral fibres of the baboon
1974
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
HPLC Analysis of Reduced and Oxidized Coenzyme Q10 in Human Plasma
2001
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
1998 StandoutScience
Pregnancy, oral contraceptives and multiple sclerosis*
2009
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Mitochondrial myopathies
1985
Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
1987 Standout
Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man
1987
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role ofPGC1andNRF1
2003 Standout
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway
2001 StandoutNobel
Microvascular Deposition of Complement Membrane Attack Complex in Dermatomyositis
1986
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
2010 Standout
Cannabinoids for Medical Use
2015 Standout
Fatal Polymyositis in D-Penicillamine-Treated Rheumatoid Arthritis
1983
Cerebral venous thrombosis
2004
Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention
1984
Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.
2000
Design of the mammalian respiratory system. VI. Distribution of mitochondria and capillaries in various muscles
1981
ANTICIPATION IN MYOTONIC DYSTROPHY: FACT OR FICTION?
1989
Assessment of disease progression in motor neuron disease
2005
Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
2003 StandoutScience
Anti-spasticity agents for multiple sclerosis
2003
Serotonin (5-HT) and pain: A reappraisal of its role in the light of receptor multiplicity
1995
Adverse Effects of Drugs on Muscle
1982
Works of F. Jerusalem being referenced
Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b
1988
Exogenous coenzyme Q (CoQ) fails to increase CoQ in skeletal muscle of two patients with mitochondrial myopathies
1990
Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus
1989
Inclusion body myositis : clinical and histopathological features of 36 patients
1993
Sympathetic skin response abnormalities in amyotrophic lateral sclerosis
1993
[Cerebral venous and sinus thrombosis with special consideration of the topography of hemorrhagic infarction].
1965
Cytogenetic findings in two brothers with ataxia-telangiectasia (Louis Bar's syndrome).
1972
Letters to the editor
1994
[Lactate and pyruvate blood levels in the diagnosis of mitochondrial myopathies].
1989
Morphometric analysis of skeletal muscle capillary ultrastructure in inflammatory myopathies
1974
DUCHENNE DYSTROPHY
1974
DUCHENNE DYSTROPHY
1974
Myotonic dystrophy?Early detection and genetic counselling
1980
Neuropathy and monoclonal IgM M-protein with antibody activity against gangliosides
1987
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
1998
[Myopathological and immunological findings in the diagnosis and pathogenesis of polymyositis and dermatomyositis (author's transl)].
1980
[Double-blind study on the antispastic effect of beta-94-chlorphenyl)-gamma aminobutyric acid (CIBA) in multiple sclerosis].
1968
Hyperreactive (hyaline, opaque, dark) muscle fibers in Duchenne dystrophy
1978
Cytoplasmic body neuromyopathy presenting as respiratory failure and weight loss
1979
[Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
1981
Human muscle fiber fine structure
1975
Mitochondria-Lipid-Glycogen (MLG) Disease of Muscle
1973
[Management of multiple sclerosis].
1968